AI-generated summary
The authors report a preliminary randomized study of 21 patients with refractory vitiligo, comparing tacrolimus ointment plus 308 nm excimer lamp with or without fractional CO2 laser. They found no statistically significant improvement in repigmentation on the laser-treated side, and only localized adverse effects were noted. The authors suggest that insufficient tacrolimus penetration through laser-made holes may explain the lack of benefit.
- Participants
- 21
- Who or what was studied
- Patients with multiple, localized, refractory, non-segmental vitiligo lesions
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract describes this as a preliminary study with a small sample of 21 patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 308 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.